This trial tests the safety and effects of a drug on heart rhythm, how the body processes it, and how it affects the body.
1 Primary · 15 Secondary · Reporting Duration: Days 6 and 10: Pre-dose up to 24 hours
3 Treatment Groups
1 of 3
1 of 3
1 of 3
72 Total Participants · 3 Treatment Groups
Primary Treatment: Group 1 · Has Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 55 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the enrollment of individuals over 55 years old permissible in this trial?
"The age range for this research is 18-55 years old." - Anonymous Online Contributor
Has Group 1 gained regulatory approval from the U.S. Food and Drug Administration?
"Since this is a Phase 1 trial, with limited data concerning its safety and efficacy, we at Power rate Group 1's security as a score of 1." - Anonymous Online Contributor
Am I qualified to access the benefits of this experiment?
"Qualifying individuals must demonstrate symptoms of pain and be between the ages 18 and 55 in order to join this medical research. The trial is looking for approximately 72 participants." - Anonymous Online Contributor
Is the recruitment process of this trial still underway?
"According to information presented on clinicaltrials.gov, recruitment for this medical study is ongoing and the trial was originally posted on April 12th 2023 with a recent update being made May 5th 2023." - Anonymous Online Contributor
How many participants are being administered the treatment in this research endeavor?
"Yes, the information hosted on clinicaltrials.gov verifies that this research venture is actively seeking out participants. This trial was originally posted April 12th 2023 and has been revised as recently as May 5th 2023. 72 individuals are being sought from 2 distinct sites for enrollment in this study." - Anonymous Online Contributor